-
JNJ-64619178
- names:
JNJ-64619178
- CAS号:
2086772-26-9
MDL Number: - MF(分子式): C22H23BrN6O2 MW(分子量): 483.36
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM003021-5mg | 5mg | 99.02% | ¥ 3915.00 | ¥ 3915.00 | 2-3天 | ¥ 0.00 | ||
| YZM003021-1mg | 1mg | 99.02% | ¥ 1300.00 | ¥ 1300.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | |
| CAS号 | 2086772-26-9 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C22H23BrN6O2 |
| 分子量 Molecular Weight | 483.36 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度125 mg/mL(258.61 mM;Need ultrasonic) |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
JNJ-64619178(CAS:2086772-26-9)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
| 产品说明 | JNJ-64619178 是一种有效的伪不可逆的、口服有效的、选择性PRMT5抑制剂,IC50为 0.14 nM |
| Introduction | JNJ4619178 is a selective, orally active and pseudorreversiblePRMT5inhibitor with anIC50of 0.14 nM. JNJ4619178 has potent activity In lung cancer[2]. |
| Application1 | |
| Application2 | |
| Application3 |
JNJ-64619178 是一种有效的伪不可逆的、口服有效的、选择性PRMT5抑制剂,IC50为 0.14 nM。JNJ-64619178 有治疗肺癌的潜力。JNJ-64619178 is a selective, orally active and pseudo-irreversiblePRMT5inhibitor with anIC50of 0.14 nM. JNJ-64619178 has potent activity In lung cancer[1][2].
【1】.Tongfei Wu, et al. Abstract 4859: JNJ-64619178, a selective and pseudo-irreversible PRMT5 inhibitor with potent in vitro and in vivo activity, demonstrated in several lung cancer models.
【2】.Tao H, et al. Discovery of Novel PRMT5 Inhibitors by Virtual Screening and Biological Evaluations. Chem Pharm Bull (Tokyo). 2019;67(4):382-388.
【2】.Tao H, et al. Discovery of Novel PRMT5 Inhibitors by Virtual Screening and Biological Evaluations. Chem Pharm Bull (Tokyo). 2019;67(4):382-388.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


